skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Method for protection against genotoxic mutagenesis

Patent ·
OSTI ID:870650

A method and pharmaceutical for protecting against mutational damage in mammalian cells, irrespective of the nature of the mutagenic event or source of radiational or chemical insult or the like.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
DOE Contract Number:
W-31109-ENG-38
Assignee:
Arch Development Corporation (Chicago, IL)
Patent Number(s):
US 5567686
OSTI ID:
870650
Country of Publication:
United States
Language:
English

References (26)

Inhibition of topoisomerase II activity in repair-proficient CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065) report September 1992
The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells journal January 1985
Mitochondrial DNA alterations as ageing-associated molecular events journal September 1992
Oxidative and other DNA damages as the basis of aging: a review journal September 1992
Endogenous glutathione levels modulate the frequency of both spontaneous and long wavelength ultraviolet induced mutations in human cells journal January 1992
Differential radioprotection of cultured human diploid fibroblasts and fibrosarcoma cells by WR1065 journal January 1991
Protection against Radiation-Induced Mutagenesis in V79 Cells by 2-[(Aminopropyl)amino] Ethanethiol under Conditions of Acute Hypoxia journal February 1989
Differential Effects of Radical Scavengers on X-Ray-Induced Mutation and Cytotoxicity in Human Cells journal January 1987
Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326 journal January 1992
Enhancement of Topoisomerase I-Mediated Unwinding of Supercoiled DNA by the Radioprotector WR-33278 journal October 1990
The inhibitory effect of cysteine on the mutagenic activities of several carcinogens journal August 1978
The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in mouse splenocytes when administered prior to or following irradiation journal January 1992
Preface: Aging of the 25th chromosome journal September 1992
Chemical Protection against the Long-Term Effects of a Single Whole-Body Exposure of Mice to Ionizing Radiation: I. Life Shortening journal July 1977
Models for thiol protection of DNA in cells journal January 1988
Protection by WR-2721 of human bone marrow function following irradiation journal August 1986
Protection by WR-151327 against Late-Effect Damage from Fission-Spectrum Neutrons journal October 1991
Antimutagenic Effects of Radioprotector WR-2721 Against Fission-spectrum Neutrons and 60 Co γ-rays in Mice journal January 1992
In Vivo Protection by the Aminothiol WR-2721 against Neutron-induced Carcinogenesis journal January 1992
Pathological Effects of the Radiation Protector WR-151327 in Mice journal October 1990
DNA, mutations and aging journal January 1989
Mitochondrial DNA mutation and the ageing process: bioenergy and pharmacological intervention journal September 1992
Antimutagenic properties of WR 2721 and of a radioprotective mixture, ATP-AET-serotonin, with regard to X ray induced reciprocal translocations in mouse spermatogonia journal January 1987
Protective effects of 2-[(aminopropyl)amino] ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells journal August 1986
Radiation Protectors: the Unexpected Benefits journal January 1989
Natural antioxidants as inhibitors of oxygen species induced mutagenicity journal October 1992